Coronary flow reserve (CFR) is an important index of coronary microcirculatory function. The objective of this study was to validate the reproducibility and accuracy of intravascular conductance catheter-based method for measurements of baseline and hyperemic coronary flow velocity (and hence CFR). The absolute coronary blood velocity was determined by measuring the time of transit of a saline injection between two pairs of electrodes (known distance) on a conductance catheter during a routine saline injection without the need for reference flow. In vitro validation was made in the velocity range of 5 to 70 cm/s in reference to the volume collection method. In 10 swine, velocity measurements were compared with those from a flow probe in coronary arteries at different CFR attained by microsphere embolization. In vitro, the mean difference between the proposed method and volume collection was 0.7 Ϯ 1.34 cm/s for steady flow and Ϫ0.77 Ϯ 2.22 cm/s for pulsatile flow. The mean difference between duplicate measurements was 0 Ϯ 1.4 cm/s. In in vivo experiments, the flow (product of velocity and lumen cross-sectional area that is also measured by the conductance catheter) was determined in both normal and stenotic vessels and the mean difference between the proposed method and flow probe was Ϫ1 Ϯ 12 ml/min (flow ranged from 10 to 130 ml/min). For CFR, the mean difference between the two methods was 0.06 Ϯ 0.28 (range of 1 to 3). Our results demonstrate the reproducibility and accuracy of velocity and CFR measurements with a conductance catheter by use of a standard saline injection. The ability of the combined measurement of coronary lumen area (as previously validated) and current velocity and CFR measurements provides an integrative diagnostic tool for interventional cardiology.
ISCHEMIC HEART DISEASE is complex and often involves changes in epicardial coronary arteries and myocardial microvasculature. Coronary flow reserve (CFR, ratio of maximal to baseline flow) accounts for both epicardial and microvascular resistances (7) . In the absence of epicardial artery disease, the CFR provides an index of the health of coronary microcirculation. Many patients who undergo percutaneous coronary interventions and revascularizations have low coronary flow because of both epicardial and microcirculatory disease (15, 28) .
Several methods have been used for measuring velocity or blood flow rate in animals and humans. The intracoronary Doppler wire is a well-established method for determining blood flow velocity (3, 11, 19) . The measurement relies on the detection of red blood cells moving past the ultrasound emitter/ receiver at the end of a guide wire. Although this method has been used clinically, it is angle dependent, and especially in disease vessels, it lacks the accuracy and reproducibility needed for a reliable diagnosis (17) . The thermodilution method has also been proposed for determining blood velocity (24) , but it has not garnered significant clinical utility because it requires a reference injection flow, except when only a relative flow (CFR) is desired.
Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) scans have been used clinically for coronary pertusion or regional myocardial blood flow measurements (10, 22) . SPECT is a qualitative measure because it relies on radiolabeled tracers for the flow measurements that can often be cleared from the tissue during the study. Although PET is more quantitative, it is both expensive and not a routine procedure. Neither method allows for a real-time assessment in the catheterization laboratory. Hence, there is a need for an accurate, reproducible, and real-time assessment of coronary flow along with lumen sizing capability on the same interventional device.
We have previously developed an intravascular conductance catheter [LumenRecon (LR) catheter, FlowCo, Indianapolis, IN] used to measure cross-sectional lumen area in both coronary and peripheral vessels (12) (13) (14) . The catheter has been demonstrated to be accurate and easy to use in vivo in patients (8) . Here, we added an additional capability to the LR catheter to measure blood velocity (or CFR) during a routine saline injection. The objective of this study was to validate the accuracy and reproducibility of the velocity and CFR measurements on the bench and in swine in both normal and stenotic coronary arteries.
METHODS
LR catheter and electronic setup. The LR catheter has been validated for vessel lumen area or diameter measurements by our group (8, (12) (13) (14) . The LR is a multilumen impedance catheter [2.7-Fr similar to standard intravascular ultrasound (IVUS)] with four platinum electrodes (1 mm width) at the catheter tip with customized spacing for diameter range of interest as shown in a previous publication (13) . The inner lumen of the catheter was designed for rapid exchange, using a 0.014-inch guide wire, whereas the other lumens were used to run a low impedance wire from the platinum electrodes at the catheter tip to the proximal connector. The electrodes were labeled 1 through 4, starting with the distal tip electrode.
A constant current of 35-50 A [root mean square (RMS)] was supplied by a galvanostat (Analog Bipotentiostat, Pine Research Instrumentation, Raleigh, NC). The current was a continuous 4.5-kHz sinusoidal waveform, generated by a function generator (SFG-2110 Synthesized Function Generator, GW Instek, Taiwan). The current was delivered through the two outer electrodes (1 and 4), whereas voltage changes were measured simultaneously across electrodes 1 and 2 (the distal pair) and electrodes 3 and 4 (the proximal pair). The voltage detected across the two pairs of electrodes were individually band-pass filtered (30 -10 kHz, 2nd-order high pass, 4th-order low pass) and amplified (50ϫ) using two bioelectric amplifiers (model LP 511, Astro-Med, Grass Technologies, West Warwick, RI). These signals were digitized via a data acquisition system (PowerLab 16/30, AdInstruments, Colorado Springs, CO), sampling continuously at 100 kHz per channel and streamed to disk for later analysis.
Principle of method. The measurement is based on the concept that velocity ϭ length/time and that flow ϭ velocity ϫ cross-sectional area (CSA). During the velocity/flow measurements, saline solution was injected into the vessel along the LR catheter to create an interface of different solutions with different conductivities (salineblood interface). When the solution interface reached each pair of electrodes, a rapid voltage change was identified because of the change of conductivity in a constant electrical current system (14) (Fig. 1 ). The time difference (⌬T ϭ t 2 Ϫ t1) was measured between the times at which voltage change appeared at each pairs of electrodes. This ⌬t represents the time when the solution interface travels between the two pairs of electrodes through a given distance (L). The blood velocity was calculated as V ϭ L/⌬t, where L is the distance between the midpoint of the two pairs of electrodes (1.6 cm). In the present study, the time t 1 and t2 were determined manually using LabChart software. Future studies are needed to report an automated algorithm that compares several approaches including cross-correlation, gradient, and a model-based method.
In vitro experimental setup. In vitro experiments were conducted either on sheath (tubes) with known diameter or on harvested carotid arteries (vessels) under steady or pulsatile flow conditions. The carotid artery was selected because it has a long length with a uniform CSA and no major branches. Briefly, once the animal was euthanized, the carotid arteries were exposed and the vessels were carefully dissected and harvested. The vessels were placed in saline solution, and all small branches were ligated with silk surgical suture. The vessel was cannulated with a short sheath on both ends and suspended on a bench stand. The side arm of the proximal sheath was connected to a flow source, whereas the side arm of the distal sheath was open to atmosphere.
The solution interface was created using 0.45 and 0.9% NaCl solution. For the steady flow condition, the side arm of the proximal sheath was connected to a hydrostatic head containing the 0.45 and 0.9% NaCl solutions. A three-way stopcock system was placed between the side arm of the sheath and flow source to control the flow through the tube or vessel. For steady flow measurement, the 0.45% NaCl solution (similar electrical conductivity to blood) was initially flowed through the tube or vessel for ϳ5 s. The three-way stopcock was then switched to stop the flow of the 0.45% NaCl solution to allow the flow of the 0.9% NaCl solution through the tube or vessel for 5 s. Finally, the stopcock was turned back to allow 0.45% NaCl to flow back to the system.
For the pulsatile flow measurements, the side arm of proximal sheath was connected to a constant flow pulsatile pump (Vera Varistaltic Pump Plus, Manostat/Barnant, Barrington, IL) with a 0.9% NaCl solution source. The vessel and connecting tube were prefilled with 0.45% NaCl solution. The pump was then turned on, and the 0.9% NaCl solution was allowed to flow through the system to replace the 0.45% NaCl solution. In these experiments, the LR catheter was placed in the tube or vessel through the sheath with the tip pointing in the direction of the flow. The velocity was measured as the transit of interface (0.45 and 0.9% NaCl solutions) between the two pairs of electrodes. The volume flow through the tube or vessel during the velocity measurement was simultaneously collected for 30 s by the volume collection method ("gold standard"). The volume flow velocity measurements using the LR method were compared with this standard.
During the in vitro velocity measurements in the vessel, the location of each electrode in the vessel was marked and the LR catheter was then removed. The CSA was measured by an IVUS catheter (Atlantis SR Pro 40-MHz Imaging Catheter, Boston Scientific, Natick, MA) at the same vessel location as identified by angiography. A mean CSA from these locations was used to calculate the velocity. The flow rate measured by volume collection was then converted to velocity.
In vivo measurements. The animal studies were approved by the Institutional Animal Care and Use Committee of Indiana University Purdue University Indianapolis. Ten domestic male swine (55 to 65 kg) were used for the study. The animals were fasted overnight and given an intramuscular injection of tiletamine-zolazepam (100 mg/ ml), ketamine (100 mg/ml), and xylazine (100 mg/ml) as an initial anesthetic (0.044 mg/kg). The animals were intubated and mechanically ventilated with 100% oxygen and 1-2% isoflurane. The sternum was cut open, and the heart was fully exposed. Potential arrhythmia was prevented by the dripping of lidocaine when needed during cardiac manipulation. Vital signs (heart rate, respiratory rate, partial O2 saturation, and end-tidal CO2), body temperature, ECG, and blood pressure were monitored and maintained within the physiological range during the entire experimental procedure.
In each animal, a proximal and distal portions (for stenosis) of either the left anterior descending coronary artery (LAD) or right coronary artery (RCA) were dissected away from the myocardium. A perivascular ultrasonic flow probe (Transonic Systems, Ithaca, NY) was placed around the proximal portion of each vessel. To create a stenosis, a vascular occluder (In Vivo Metric, Healdsburg, CA) prefilled with glycerin was placed around the distal portion of the vessel (Fig. 2) . After instrumentation of the probe and occluder, the sternum was approximated.
A sheath (6 Fr) was inserted into the femoral artery to allow standard access of the coronary arteries under fluoroscopic guidance. The LR catheter was advanced over the 0.014Љ guide wire to a position distal to the flow probe. The voltage across the distal and proximal electrode pairs, the ECG, and the volume flow rate from the flow probe were measured before, during, and after the injection of 10 ml 0.9% NaCl solution in the vessel. The saline injection was performed either by an infusion pump (1 ml/s; KD Scientific, Holliston, MA) or by hand (2 ml/s). After each basal flow measurement, vasodilatation was obtained by repeated intracoronary (IC) injections of 80 g adenosine in 5 ml saline, followed by flow measurement.
Different degrees of microcirculatory embolism were created by repeated IC injections of 5-ml microspheres (50 m, 2.5 mg/ml, Thermo Scientific, Fremont, CA) (23) . The flow velocity was measured under baseline conditions and during coronary vasodilatation (IC injection of adenosine) at each microcirculatory embolism condition.
Angiography was performed to locate the positions of LR electrodes in the vessel. The LR catheter was then withdrawn from the vessel. The CSAs of RCA and LAD for the regions of the LR electrodes and the flow probe were then measured by IVUS under baseline conditions and after IC adenosine injections. Once LR velocity was determined as described here, LR volume flow rate was calculated by multiplying the velocity by the average IVUS CSA. The velocity was also measured under stenotic conditions with inflation of the occluder by glycerin injection. The degree of the stenosis was controlled by the volume of glycerin injected into the cuff and confirmed by reduction of coronary flow (by flow probe) and lumen CSA (by IVUS).
Data analysis. Under each condition, the measurement was repeated four times and an average value was considered. The correlation between test (LR catheter) and control measurements (flow collection or flow probe) was determined in a scatterplot with a linear least-squares fit and the corresponding correlation coefficient (R 2 ). The degree of agreement between different methods for the measurements was assessed by the Bland-Altman analysis (4). The significance of difference between the measurements of the two methods was examined by Wilcoxon analysis. P Ͻ 0.05 was considered to be significant.
RESULTS
The resolution of the proposed method depends on an accurate measurement of ⌬t since L is known. Therefore, the fractional or percent error in velocity is proportional to the fractional error in ⌬t. Based on current measurement system, we determined that the resolution of ⌬t is ϳ5 ms with mean ⌬t of 0.5 s in the velocity range of interest. Hence, the fractional error is 1%, which at coronary velocity range of 1-20 cm/s, implies a velocity resolution of 0.01-0.2 cm/s.
In vitro validation. In a tube with uniform diameter, both flow rate and velocity were constant along the entire length of the tube. The velocity was calculated from the flow rate and CSA of the tube. Figure 3 shows the correlation between velocities measured in the tube by the LR catheter and the volume collection method as expressed by linear least-squares fit. The measured flow velocity range in the tube was between 7 and 70 cm/s. A correlation between the velocities measured by LR and volume collection method under either steady or pulsed (50 to 140 pulses/min) flow condition was highly significant: V LR ϭ 0.97V vol ϩ 0.30 (R 2 ϭ 0.997) for steady flow and V LR ϭ 1.05V vol Ϫ 0.89 (R 2 ϭ 0.993) for pulsatile flow. In a Bland-Altman plot, the mean differences between the two measurements were 0.7 Ϯ 1.3 cm/s for steady flow and Ϫ0.77 Ϯ 2.2 cm/s for pulsatile flow, which were not statistically different from zero as shown in Table 1 (i.e., lack of bias between the 2 methods). Figure 3 also shows the correlation of velocity measured by LR and volume collection in an elastic carotid artery under pulsatile condition. The maximum velocity measured was smaller than the respective measurements in the tube, since the pump used in this study created large vessel distension at peak flow rate due to elasticity of the vessel. The measurements by the two methods also correlated very well in the vessel as V LR ϭ 0.90V vol ϩ 0.22 (R 2 ϭ 0.978). The LR catheter slightly underestimated the velocity compared with volume collection control. The difference was 1.59 Ϯ 2.0 cm/s (mean Ϯ SD, P ϭ 0.05) in the velocity range of 5 to 40 cm/s. The RMS error was 0.65% and 11.4% of the mean of the volume collection method for pulsatile velocity in the tube and the vessel, respectively. The greatest error in the vessel measurements is likely due to the variability of vessel that propagated the error in velocity. Figure 4 shows the reproducibility of the LR catheter velocity measurement in vitro. The linear least-squares fit of the relation between the two measurements were found as V 1st ϭ 0.96V repeat ϩ 1.0 (R 2 ϭ 0.997) for tube steady flow, V 1st ϭ 0.99V repeat ϩ 0.14 (R 2 ϭ 0.999) for tube pulsatile flow, and V 1st ϭ 0.96V repeat ϩ 1.02, (R 2 ϭ 0.997) for pulsatile flow in a vessel. The mean difference between the two measurements was nearly zero with a relatively small SD (Table 1) .
Since the in vivo control measurement of flow is made with flow probe during the saline injection, the accuracy of the flow probe was first validated for saline in vitro as shown in Fig. 5 . The flow probe measurement generally correlated well with volume collection but with an offset or bias. The difference between the flow rates measured by volume collection and flow probes was 20 Ϯ 21 ml/min (P ϭ 0.0004) in the range of 40 to 400 ml/min.
CFR measurements. In the in vivo experiments, the velocity was measured by the LR catheter in the distal portion of the coronary artery. Because of the variations of the vessel CSA between the distal and proximal portion, the velocity was somewhat different between these locations. In the absence of major branches, the blood flow rate is expected to be the same along the length between the flow probe and LR catheter. In the in vivo measurements, the blood flow velocity was first measured by LR catheter and then the flow rate was calculated based on the measured coronary CSA. The correlation between the two flow measurements by LR catheter and flow probe in RCA and LAD was calculated and shown in Fig. 6A as Flow LR ϭ 0.91 Flow Probe ϩ 5.39 (R 2 ϭ 0.861). The BlandAltman plot showed that the mean difference between the two measurements was Ϫ1.6 Ϯ 10 (mean Ϯ SD). This difference was not significantly different from zero (P ϭ 0.12) in the range of 10 to 130 ml/min. The RMS error was 33% of the mean of the two measurements. The velocity was also measured by the LR catheter under stenotic conditions. As shown The mean and SD are analysis of the differences between 2 different methods and are plotted in the Bland-Altman plots in different figures. P value is from Wilcoxon analysis for the significance of the difference of 2 measurements from 0. R 2 is the correlation coefficients from linear correlation analysis. RCA, right coronary artery; LAD, left anterior descending coronary artery. in Fig. 6 , the flows measured by LR and flow probe were well correlated and comparable in accuracy with those without stenosis.
The CFR was measured in both RCA and LAD with the LR catheter. The CFR was first measured at baseline with an average value of 3. The CFR was then repeatedly measured under reduced flow conditions made by multiple microsphere injections into the test vessel until CFR was reduced to nearly 1. The CFR LR correlated well with the CFR Probe in both RCA and LAD (CFR LR ϭ 0.79CFR Probe ϩ 0.41; R 2 ϭ 0.706) as shown in Fig. 7 . The Bland-Altman analysis showed good agreement between CFR LR and CFR Probe , where the mean difference between the two methods was nearly zero (Table 1) . This difference between the two measurements was not statistically significant. The RMS error was 20% of the mean of the two measurement methods.
DISCUSSION
This study demonstrated that an intravascular LR catheter can measure velocity and CFR in swine coronary arteries accurately and reproducibly under both normal and stenotic conditions. The same 2.7-Fr catheter was previously shown to accurately and reproducibly measure lumen CSA (12, 14) . Currently, there is no combination device that measures both CFR and CSA simultaneously. This combined capability that allows real-time measurement of lumen lesion dimensions and CFR is of value to coronary physiology and cardiology.
Although other methods are currently used for intravascular flow and CFR measurements, the LR catheter has potential advantages, simplicity and accuracy. Doppler flow wires can be used during interventional cases for CFR measurement (2, 25) . Since the measurement relies on a specific angle between the ultrasound beam and the vessel direction, the accuracy is difficult to control and requires significant manipulation, especially in diseased, tortuous vessels (18) . Thermodilution has been previously used to measure blood flow in the coronary sinus (6) , and the application of flow measurement in selective coronary arteries has been recently reported (1) . The thermodilution method requires a known infusion rate for saline with known temperature for absolute velocity measurements. The LR method does not depend on the infusion rate where a range of infusion rates (2-4 ml/s by hand or with injector) produces similar results. Furthermore, the method is based on a transit time principle over a known distance and does not require knowledge of the injection rate. The measurement can be made in real time with adenosine in the saline solution (IC) to measure hyperemic flow. The same injection can produce measurements of lumen CSA as previously reported (8, 12, 14) .
The physical principle of the measurement was demonstrated in in vitro experiments that lack the inherent variability of in vivo comparisons. A plastic sheath with fixed diameter was used to eliminate the diameter variations, which can complicate the comparison. The in vitro experiments showed excellent reproducibility and accuracy, attesting to the rigor of the physical principle.
The in vivo variability between the LR catheter measurement and the flow probe is significantly greater than that of the in vitro (Fig. 6 , and Table 1 ). The accuracy of the flow probe has been questioned in larger vessels under certain conditions (27) . As shown in bench experiments, the flow probe underestimated flow rate compared with the volume collection method (Fig. 5, and Table 1 ). These differences may be amplified under in vivo conditions when flow is pulsatile. Furthermore, the flow probe was placed on the proximal portion of the artery, but the LR catheter measured the velocity of the distal portion of the vessel. The LR catheter was passed through the flow probe and can cause disturbance of flow measured by the flow probe. Finally, the conversion of measured velocity to flow rate requires CSA measurement. IVUS measurement can introduce additional inaccuracy in the measurement, including possible vasospasm (12) .
The in vivo velocity measurement by the LR catheter was made at the start of the saline injection (first 1 to 2 s). The voltage changes at the saline-blood interface were sharper, and the ⌬t estimation was more accurate. Although there was a The cross-sectional area of the vessel was measured by intravascular ultrasound at site of each electrode and then converted to the value equivalent to LR catheter measurement according to the correlation curve previously determined between LR catheter and intravascular ultrasound. The flow rate was computed based on these measurements and compared with direct flow measurement made by FP simultaneously. The white symbols represent the measurement under the stenotic conditions. Under this condition, most data collected were within the range of lower flow rate and many of them were overlapped with other data points. The reduction of cross-sectional area was in the range up to 90%. The correlation between the measurements by 2 methods were determined in scatterplot with a linear least-squares fit (A). The degree of agreement between 2 measurements was assessed by the BlandAltman analysis (B). second voltage change due to the replacement of saline by blood (blood-saline interface) (Fig. 1 , the voltage recovery portion), it is more gradual and the ⌬T measurements were less accurate. This could be due to the blood-saline mixing or physiological changes in the system including hyperemic response. In this context, it has been shown that image contrast, blood or saline injection, into both peripheral and coronary arteries can cause blood flow changes several seconds after the injection (9, 16, 20, 21, 26, 29) . It has also been shown that the change of flow caused by saline or blood injection depends on the injection speed, injection quantity, type of the guide catheter, and distance between injection and flow recording site (9, 29) . The change in blood flow has been shown to be small within 2 s of injection (9, 21) . Indeed, previous reports confirmed that blood flow was not changed significantly within 2 s after injection with an injection velocity of 2-4 ml/s in the coronary arteries (20, 21) . In this study, we used mean flow within a 2-s window after the saline injection for in vivo measurements at relatively low injections (1 to 2 ml/s) to not affect the blood flow (Fig. 1) . Under this condition, the velocity measured represents undisturbed blood velocity. This was supported by studies in coronary flow measurements using different methods by various groups (1, 5, 20, 21) . In studies of flow measurements with contrast dilution method, the data were collected in a 2-to 3-s time period, beginning at injection of contrast (20, 21) . The blood flow was also measured during saline injections in the thermodilution method (1, 5) .
Although the velocity and CSA by the LR catheter were not measured simultaneously in this study, the validation of this methodology for CSA measurement (in comparison to IVUS) has been previously confirmed (12) . If we use the previous measurements to convert the CSA measured by IVUS in this study to those measured by LR catheter, we obtain the same accuracy conclusions. Since the focus here was on flow velocity and CFR measurements, we measured the lumen dimension with the IVUS ("gold standard"). Our long-term objective is to translate the technology to a 0.014Љ guide wire and validate it in the clinic for simultaneous CSA and velocity in a human system that presently does not exist on a single interventional device. The present study serves as the foundation that establishes the physics of the principle along with extensive in vitro and in vivo validation.
In summary, the study presents an intravascular catheter for velocity and CFR measurements. This method is accurate, reproducible, and easy to perform using a hand injection. The clinical validation of this method for simultaneous assessment of vessel sizing (as demonstrated previously) and microcirculatory function is warranted.
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